Florida A&m University

Xue You Zhu

Seth Y Ablordeppey

Nkafu Bechem Ndemazie

Edward Agyare

Andriana Inkoom

Novel compounds and methods of using the compounds and compositions to treat pancreatic cancer are presented. Novel compounds N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)octanamide and N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)dodecanamide are provided. The compounds have been shown to induce cytotoxicity in pancreatic cancer cells and can serve as a novel oral treatment for pancreatic cancer.

Pyrimidine nucleosides as anticancer agents against pancreatic cancer

A method of treating psychosis, and the underlying antipsychotic formulation. The method includes administering a therapeutically effective amount of synthetic agents that selectively recruit &#x3b2;-arrestin to D2 receptors and have little-to-no binding to culprit receptors associated with weight gain and Type II diabetes. The synthetic agents can include SYA16263 and SYA16264, and/or derivatives or analogs thereof. The 1-(pyridin-2-yl)piperazine moiety was found to play a significant role in recruiting &#x3b2;-arrestin to D2 receptors. In other embodiments, the current invention relates to synthetic agents that are selective of D4 receptors for treatment of psychosis and erectile dysfunction. The synthetic agents can include SYA27287 and/or derivatives or analogs thereof. In all embodiments, extrapyramidal side effects are eliminated or minimized.

Growing community of inventors

Tallahassee, FL, United States of America

Xue You Zhu